When you guessed producers, you could possibly be flawed. A minimum of this is in line with a brand new find out about by way of Mattingly et al. (2023) in JAMA Well being Discussion board. The use of a pattern of the 45 generic medication with >$100m in Section D and utilized by >1m beneficiaries, the authors discovered that:
…Medicare Section D spent $11.8 billion for 690 million claims (imply, $22.50 consistent with declare; 95% CI, $18.28-$26.72 consistent with declare), representing 5.5% of all Section D spending ($216 billion) in 2021. The $22.50 used to be allotted as follows: $9.18 (40.8%) represents PBM gross benefit; $3.87 (17.2%), pharmacy gross benefit; $2.71 (12.0%), wholesaler gross benefit; and $6.73 (29.9%), producer income. Overall middleman gross benefit (PBM, wholesaler, and pharmacy) ranged from −12.3% to 88.6% of Medicare Section D spending.
The total paper is right here.